Načítá se...
Rabeprazole sodium delayed-release multiparticulates: Effect of enteric coating layers on product performance
Rabeprazole sodium is one of the most effective proton pump inhibitors (PPIs) used in antiulcer therapy. Like most other PPIs, owing to its acid-labile nature, the drug is formulated as enteric-coated dosage form. Conventional means of producing delayed release multiparticulate dosage forms of PPIs...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Medknow Publications Pvt Ltd
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3217710/ https://ncbi.nlm.nih.gov/pubmed/22171316 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2231-4040.85539 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|